A case of familial mediterranean fever with seconder amyloidosis and intrahepatic cholestasis signs

Yıl 2005, Cilt: 4 Sayı: 2, 117 - 120, 01.08.2005

Cem Şahan Kuddusi Cengiz

Öz

Familial Mediterranean fever (FMF) is an autosomal recessive hereditary disease which primarily affects populations surrounding the Mediterranean basin. One of the most significant complications of FMF is amyloidosis. The amyloid is of the AA type, which is typical of secondary amyloidosis. We report a case of a 24-year-old male with intrahepatic cholestasis, hepatic amyloid and FMF. The patient died because of renal involvement after 14 months.

Anahtar Kelimeler

Familial Mediterranean fever, amyloidosis, intrahepatic cholestasis, liver

İntrahepatik kolestazla başvuran sekonder amiloidozlu Ailevi Akdeniz Ateşi olgusu

Öz

Ailevi Akdeniz Ateşi Akdeniz havzasında yaşayan popülasyonu etkileyen otozomal resesif bir hastalıktır. Ailevi Akdeniz Ateşi'nin en yaygın komplikasyonlarından biri amiloidozdur. Amiloid AA tipidir ve sekonder amiloidoza özgüdür. İntrahepatik kolestaz, hepatik amiloidoz ve Ailevi Akdeniz Ateşli bir olgu sunumu yapılmıştır. Bu hasta tanıdan 14 ay sonra renal tutulum nedeniyle ölmüştür.

Anahtar Kelimeler

Ailevi Akdeniz Ateşi, amiloidoz, intrahepatik kolestaz, karaciğer

Kaynakça

• Ben-Chetrit E, Levy M. Familial Mediterranean Fever. The Lancet 1998; 351: 659-663.
• Matzner Y. Biologic and clinical advences in Familial Mediterrane- an fever. Crit Rev Oncol Hematol 1995, 18: 197-204.
• Sohar E, Gami J, Pros M, et al. Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 1967; 43: 227-253.
• Pros E, Langevitz P, Livneh A, et al. Genotype-phenotype correlati- on in Familial Mediterranean fever: A preliminary report. In Sohar E, Gafni J, Pross M.(eds). Proceedings of the 1st İnternational con- ference on FMF (Jerusalem, 1997). Tel-Aviv; Frude. 1997; 260-264.
• Lovet LB, Persey MR, Madhoo S, et al. The liver in systemic amylo- idosis: İnsights from 123I serum amyloid P component scintigraphy in 484 patients. Gut 1998; 42: 727-734.
• Rubinow A, Koff RS, Cohen AS. Severe intrahepatic cholestasis in primary amyloidosis a report of four cases and review of the litera- ture. Am J Med 1978; 64: 937-946.
• Peters RA, Koukoulis G, Gimson a, et al. Primary amyloidosis and severe intrahepatic cholestatic jaundice. Gut 1994; 35: 1322-1325.
• Dişlen N, Koniçe M, Aral O, et al. General characteristics of our 426 cases of FMF. The first symposium on recurrent hereditary polyserositis. April 28-29, 1990. Amman Jordan Abstract Book, 22.
• Saatçi U, Tınaztepe K, Özdemir S, et al. Familial Mediterranean fe- ver in children report of large series and discussion of the risk an prognostic factors of amyloidosis.Eur J Pediatr 1997, 156: 619-623.
• Paydaş P. Report on 59 patients with renal amyloidosis. Int Urol Nephrol 1999; 31(5): 619-631.
• Harrison RF, Hawkins PN, Roche WR, et al. Fragile liver and mas- sive hepatic haemorrhage due to hereditary amyloidosis. Gut 1996; 38: 151-152.
• Levy M, Fryd DH, Eliakin M. Intrahepatic obstructive jaundice due to amyloidosis of the liver: A case report and review of the literatu- re. Gastroenterology 1971; 61: 234-238.
• Finkelstein SD; Fornasier VL, Pruzanski W, et al. Intrahepatic cho- lestasis with predominant pericentral deposition in systemic amylo- idosis. Hum Pathol 1981; 12: 470-472.
• Melkebeke P, Vandepitte J, Hannon R, et al. Huge hepatomegaly, jaundice and portal hypertension due to amyloidosis of the liver. Di- gestion 1980; 20: 351-357.
• Melate M, Manconi R, Magris D, et al. Different morphologic as- pects and clinical features in massive hepatic amyloidosis. Digesti- on 1984; 29: 138-145.
• Cox R. Amyloidosis of the liver causing jaundice. Postgrad med j. 1979; 72: 891-892.
• Rubio PA, Farrell EM, Lehane DE. Primary liver amyloidosis pro- ducing obstructive jaundice. South Med J. 1979; 72: 893-895.
• Hoffman MS, Stein BE, Davidion MM, et al. Hepatic amylodiosis presenting as severe intrahepatic cholestasis: A Case report and re- view of the literature. AJG. 1988; 83(7): 783-785.
• Gastineau DA; Gertz MA, Daniles TM, et al. Inhibitor of the throm- bin time in systemic amyloidosis. a common coagulation abnorma- lity. Blood 1991; 77: 2637-2640.
• Glenner GG. Factor X deficiency and systemic amyloidosis. N Engl J Med 1977; 1008: 297-304.
• Galbraith PA, Sharmo N, Parker W, et al. Acquired factor X defici- ency. Altered plasma antitrombin activity and association with amy- loidosis. JAMA 1974; 230: 1698-1702.
• Furie B, Grene E, Furie BC. Syndrome of acquired factor X defici- ency and systemic amyloidosis. NEJM 1977; 297: 81-87.
• Gertz MA, Kyle RA. Hepatic amyloidosis: the natural history in 80 patients. Am J Med 1988; 85: 73-80.
• Stauffer MH, Gross JB, Foulk WT, et al. Amyloidosis: diagnosis with needle biopsy of the liver in eighteen patients. Gastroentero- logy 1961; 41: 92-96.